Advertisement

Ophthalmic Manifestations

  • Janet L. Davis
  • Alan G. Palestine

Keywords

Acquire Immune Deficiency Syndrome Cytomegalovirus Retinitis Molluscum Contagiosum Herpes Simplex Keratitis Acute Retinal Necrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schwartz JJ, Myskowski PL: Molluscum contagiosum in patients with human immunodeficiency virus infection: A review of twenty-seven patients. J Am Acad Dermatol 1992, 27:583–588.PubMedCrossRefGoogle Scholar
  2. 2.
    Robinson MR, Udell IJ, Garber PF, et al.: Molluscum contagiosum of the eyelids in patients with acquired immune deficiency syndrome. Ophthalmology 1992, 99:1745–1747.PubMedGoogle Scholar
  3. 3.
    Sandor EV, Millman A, Croxson TS, Mildvan D: Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS). Am J Ophthalmol 1986, 101:153–155.PubMedGoogle Scholar
  4. 4.
    Sellitti TP, Huang AJ, Schiffman J, Davis JL: Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis. Am J Ophthalmol 1993, 116:297–301.PubMedGoogle Scholar
  5. 5.
    Litoff D, Catalano RA: Herpes zoster optic neuritis in human immunodeficiency virus infection. Arch Ophthalmol 1990, 108:782–783.PubMedCrossRefGoogle Scholar
  6. 6.
    McLeish W, Pflugfelder SC, Crouse C, et al.: Interferon treatment of herpetic keratitis in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol 1990, 109:93–95.PubMedGoogle Scholar
  7. 7.
    Young TL, Robin JB, Holland GN, et al.: Herpes simplex keratitis in patients with acquired immune deficiency syndrome. Ophthalmology 1989, 96:1476–1479.PubMedGoogle Scholar
  8. 8.
    Schwartz DA, Visvesvara GS, Diesenhouse MC, et al.: Pathologic features and immunofluorescent antibody demonstration of ocular microsporidiosis (Encephalitozoon hellem) in seven patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993, 115:285–292.PubMedGoogle Scholar
  9. 9.
    Buus DR, Pflugfelder SC, Schacter J, et al.: Lymphogranuloma venereum conjunctivitis with a marginal corneal perforation. Ophthalmology 1988, 95:799–802.PubMedGoogle Scholar
  10. 10.
    Nanda M, Pflugfelder SC, Holland S: Fulminant pseudomonal keratitis and scleritis in human immunodeficiency virus-infected patients. Arch Ophthalmol 1991, 109:503–505.PubMedCrossRefGoogle Scholar
  11. 11.
    Spaide RF, Vitale AT, Toth IR, Oliver JM: Frosted branch angiitis associated with cytomegalovirus retinitis. Am J Ophthalmol 1992, 113:522–528.PubMedGoogle Scholar
  12. 12.
    Jabs DA, Enger C, Bartlett JG: Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Opthalmol 1989, 107:75–80.CrossRefGoogle Scholar
  13. 13.
    The Ocular Complications of AIDS Study Group: Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992, 326:213–220.CrossRefGoogle Scholar
  14. 14.
    Jabs DA, Enger C, Haller J, de Bustros S: Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol 1991, 109:794–799.PubMedCrossRefGoogle Scholar
  15. 15.
    Freeman WR, Friedberg DN, Berry C, et al.: Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 1993, 116:713–720.PubMedGoogle Scholar
  16. 16.
    Freeman WR, Wiley CA, Gross JG, et al.: Endoretinal biopsy in immuno-suppressed and healthy patients with retinitis: Indications, utility, and techniques. Ophthalmology 1989, 96:1559–1565.PubMedGoogle Scholar
  17. 17.
    Gross JG, Sadun AA, Wiley CA, Freeman WR: Severe visual loss related to isolated peripapillary retinal and optic nerve head cytomegalovirus infection. Am J Ophthalmol 1989, 108:691–698.PubMedGoogle Scholar
  18. 18.
    Martin DF, Dunn JP, Davis JL, et al.: Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. Am J Ophthalmol 1999, 329–339.Google Scholar
  19. 19.
    Vrabec TR, Baldassano VF, Whitcup SM : Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology 1998, 105:1259–1264.PubMedCrossRefGoogle Scholar
  20. 20.
    Davis JL, Tabandeh H, Feuer WJ, et al.: Effect of potent antiretroviral therapy on recurrent cytomegalovirus retinitis treated with the ganciclovir implant. Am J Ophthalmol 1999, 127:283–287.PubMedCrossRefGoogle Scholar
  21. 21.
    Cassoux N, Lumbroso L, Bodaghi B, et al.: Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly activated antiretroviral therapy. Br J Ophthalmol 1999, 83:47–49.PubMedCrossRefGoogle Scholar
  22. 22.
    Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Am J Ophthalmol 1997, 124:141 – 157.Google Scholar
  23. 23.
    Martin DF, Parks DJ, Mellow SD, et al.: Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 1994, 112:1531–1539.PubMedCrossRefGoogle Scholar
  24. 24.
    Arevalo JF, Gonzalez C, Capparelli EV, et al.: Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 1995, 172:951–956.PubMedCrossRefGoogle Scholar
  25. 25.
    Duker JS, Nielsen JC, Eagle RCJ, et al.: Rapidly progressive acute retinal necrosis secondary to herpes simplex virus, type 1. Ophthalmology 1990, 97:1638.PubMedGoogle Scholar
  26. 26.
    Margolis TP, Lowder CY, Holland GN, et al.: Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1991, 112:119–131.PubMedGoogle Scholar
  27. 27.
    Heinemann MH, Bloom AF, Horowitz J: Candida albicans endophthalmitis in a patient with AIDS: Case report. Arch Ophthalmol 1987, 105:1172–1173.PubMedCrossRefGoogle Scholar
  28. 28.
    Brod RD, Flynn HJ, Clarkson JG, et al.: Endogenous Candida endophthalmitis: Management without intravenous amphotericin B. Ophthalmology 1990, 97:666–672.PubMedGoogle Scholar
  29. 29.
    Kupfer C, McCrane E: A possible cause of decreased vision in cryptococcal meningitis. Invest Ophthalmol 1974, 13:801–804.PubMedGoogle Scholar
  30. 30.
    Cochereau MI, LeHoang P, Lautier FM, et al.: Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol 1992, 114:130–135.Google Scholar
  31. 31.
    Iannucci AA, Hart LL: Clindamycin in the treatment of toxoplasmosis in AIDS. Ann Pharmacother 1992, 26:645–647.PubMedGoogle Scholar
  32. 32.
    Kovacs JA: Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program. Lancet 1992, 340:637–638.PubMedCrossRefGoogle Scholar
  33. 33.
    Elkins BS, Holland GN, Opremcak EM, et al.: Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology 1994, 101:499–507.PubMedGoogle Scholar
  34. 34.
    Rao NA, Zimmerman PL, Boyer D, et al.: A clinical, histopathologic, and electron microscopic study of Pneumocystis carinii choroiditis. Am J Ophthalmol 1989, 107:218–228.PubMedGoogle Scholar
  35. 35.
    Dugel PU, Rao NA, Forster DJ, et al.: Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. Am J Ophthalmol 1990, 110:113–117.PubMedGoogle Scholar
  36. 36.
    Blodi BA, Johnson MW, McLeish WM, Gass JD: Presumed choroidal tuberculosis in a human immunodeficiency virus infected host. Am J Ophthalmol 1989, 108:605–607.PubMedGoogle Scholar
  37. 37.
    Pepose JS, Holland GN, Nestor MS, et al.: Acquired immune deficiency syndrome: Pathogenic mechanisms of ocular disease. Ophthalmology 1985, 92:472–484.PubMedGoogle Scholar
  38. 38.
    Davis JL, Nussenblatt RB, Bachman DM, et al.: Endogenous bacterial retinitis in AIDS. Am J Ophthalmol 1989, 107:613–623.PubMedGoogle Scholar
  39. 39.
    McLeish WM, Pulido JS, Holland S, et al.: The occular manifestations of syphilis in the human immunodeficiency virus type 1 -infected host. Ophthalmology 1990, 97:196–203.PubMedGoogle Scholar
  40. 40.
    Young SH, Morlet N, Heery S, et al.: High-dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis. Med J Aust 1992, 157:370–373.PubMedGoogle Scholar
  41. 41.
    Alvarez R, Adan A, Martinez JA, et al.: Haematogenous Serratia marcescens endophthalmitis in an HIV-infected intravenous drug addict. Infection 1990, 18:29–30.PubMedCrossRefGoogle Scholar
  42. 42.
    Shafran SD, Deschenes J, Miller M, et al.: Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol: MAC Study Group of the Canadian HIV Trials Network [letter]. N Engl J Med 1994, 330:438–439.PubMedCrossRefGoogle Scholar

Selected Bibliography

  1. Engstrom RE, Holland GN, Margolis TP, et al.: The progressive outer retinal necrosis syndrome: A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology 1994, 101:1488–1502.PubMedGoogle Scholar
  2. Freeman WR, Friedberg DN, Berry C, et al.: Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 1993, 116:713–720.PubMedGoogle Scholar
  3. Martin DF, Parks DJ, Mellow SD, et al.: Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 1994, 112:1531–1539.PubMedCrossRefGoogle Scholar
  4. Studies of the Ocular Complications of AIDS Research Group with the AIDS Clinical Trials Group: Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. ARch Ophthalmol 1996, 114:23–33.CrossRefGoogle Scholar
  5. Studies of the Ocular Complications of AIDS Research Group with the AIDS Clinical Trials Group: Foscarnet-ganciclovir cytomegalovirus retinitis trial 4: Visual outcomes. Ophthalmology 1994, 101:1250–1261.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Janet L. Davis
  • Alan G. Palestine

There are no affiliations available

Personalised recommendations